Fig. 2From: SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradationRelative SPAG5 expression and its clinical significance. a and b, Kaplan-Meier curves for overall survival (OS) and disease-free survival (DFS) of two groups defined by low (n = 43) and high (n = 93) expression of SPAG5 in patients with HCC. *p < 0.05Back to article page